| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $190.5M | +101.4% |
| Cost of Revenue | $24.0M | -79.3% |
| Gross Profit | $22.7M | +196.3% |
| R&D Expense | $31.4M | -8.6% |
| SG&A Expense | $208.5M | +36.4% |
| Operating Income | -$235.2M | -15.2% |
| Pre-tax Income | -$214.7M | -3.1% |
| Income Tax | $209K | +226.6% |
| Net Income | -$214.9M | -3.2% |
| EPS (Basic) | -$2.74 | +50.8% |
| EPS (Diluted) | -$2.74 | +50.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.6M | +197.9% |
| Accounts Receivable | $8.4M | +193.9% |
| Inventory | $28.2M | +437.3% |
| Current Assets | $229.1M | +231.4% |
| Total Assets | $597.3M | +96.5% |
| Current Liabilities | $153.1M | +39.8% |
| Total Liabilities | $295.5M | +147.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$131.6M | +12.3% |
| Capital Expenditures | $846K | +69.2% |
| Investing Cash Flow | -$215.7M | -483.1% |
| Financing Cash Flow | $443.4M | +1291.4% |
| Free Cash Flow | -$132.5M | +12.1% |
| Stockholders' Equity |
| $301.7M |
| +135.1% |